Summary
Sunset Capital Assets Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 225 | $0.78 | - | -$0.78 | -100% |
 Chris Davis Davis Selected Advisers | 889,720 | $2,898.31 | - | -$2,898.31 | -100% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 1,189 | $0.4 | - | -$0.4 | -100% |
| YA Yinka Akinsola Blue Trust Inc. | 201 | $0.02 | - | -$0.02 | -100% |
| MD Michelle Dubey Yousif Capital Management LLC | 32,758 | $1,297.05 | - | -$1,297.05 | -100% |
Sunset Capital Assets Inc. (SNST) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sunset Capital Assets Inc. ever had a stock split?
Sunset Capital Assets Inc. Profile
| Household Products Industry | Consumer Staples Sector | Tom Fitzgerald CEO | OTC PINK Exchange | 867892101 CUSIP |
| US Country | 75 Employees | - Last Dividend | 26 Jan 2012 Last Split | - IPO Date |
Overview
Aphex BioCleanse Systems, Inc. is a pioneering company that focuses on the development of non-alcoholic sanitizing solutions. Established in 2010 and headquartered in Rochester, New York, the company dedicates its efforts to creating innovative products designed to enhance cleanliness and hygiene standards without relying on alcohol-based components. Aphex BioCleanse Systems, Inc. seeks to address the growing demand for effective yet gentle sanitizing options in various sectors including healthcare, agriculture, and consumer goods. Through its commitment to research and development, the company aims to offer solutions that are not only effective against a wide range of pathogens but also safer for humans and the environment.
Products and Services
- Sanitizers
- Surface Disinfectants
- Wound Wash
- Solutions for Treatment of Livestock
Aphex BioCleanse Systems, Inc. offers a range of hand sanitizers formulated without alcohol. These sanitizers are designed to kill germs effectively while being gentle on the skin. Suitable for frequent use, these products aim to provide a safer alternative for individuals with sensitive skin or allergies to alcohol-based products.
The company's lineup includes surface disinfectants that are engineered to cleanse a wide variety of surfaces without leaving harmful residues. These products are ideal for both household and professional settings, ensuring environments are not only visibly clean but also hygienically safe. The non-alcoholic formulation makes it a preferable choice for places where food is prepared or children are present.
Expanding its sanitizing technology into healthcare, Aphex offers a wound wash solution specifically designed to clean injuries without the sting associated with alcohol-based products. This product promotes healing by gently disinfecting wounds, making it an excellent option for both clinical and home care use.
Aphex also extends its innovative technology to the agricultural sector by providing treatments for livestock. These solutions are formulated to maintain the health of animals by preventing the spread of bacteria and viruses without the harsh effects of alcohol. This approach ensures that livestock producers can uphold high standards of animal hygiene and welfare.
